BIOMERICA INC
For the period ended May 31, 2025. Filed Aug 29, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Aug 29, 2025
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
SIGNATURES
In accordance with Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| BIOMERICA, INC. | |
| Registrant | |
| By | /s/ Zackary S. Irani |
| Zackary S. Irani, | |
| Chief Executive Officer |
In accordance with the Exchange Act, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated:
Signature and Capacity
| /s/ Zackary S. Irani | Date: August 29, 2025 |
|---|---|
| Zackary S. Irani | |
| Director, Chief Executive Officer | |
| /s/ Gary Lu, CPA | Date: August 29, 2025 |
| Gary Lu, CPA | |
| Chief Financial Officer | |
| /s/ Allen Barbieri | Date: August 29, 2025 |
| Allen Barbieri | |
| Director, Vice-Chairman | |
| /s/ Jane Emerson, M.D., Ph.D. | Date: August 29, 2025 |
| Jane Emerson, M.D., Ph.D. | |
| Director | |
| /s/ David Moatazedi | Date: August 29, 2025 |
| David Moatazedi Director | |
| /s/ Eric Chin, CPA | Date: August 29, 2025 |
| Eric Chin, CPA | |
| Director | |
TABLE OF CONTENTS
| Report of Independent Registered Public Accounting Firm (PCAOB ID 0200) | FS-2 – FS-3 |
|---|---|
| CONSOLIDATED FINANCIAL STATEMENTS | |
| Consolidated Balance Sheets as of May 31, 2025 and 2024 | FS-4 |
| Consolidated Statements of Operations and Comprehensive Loss for the Years Ended May 31, 2025 and 2024 | FS-5 |
| Consolidated Statements of Shareholders’ Equity for the Years Ended May 31, 2025 and 2024 | FS-6 |
| Consolidated Statements of Cash Flows for the Years Ended May 31, 2025 and 2024 | FS-7 |
| Notes to Consolidated Financial Statements | FS-8 – FS-19 |
FS-1
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.